Denver practice seeks to eradicate heart disease and stroke with Arineta’s dedicated cardiac CT scanner
April 15, 2025
Caesarea, Israel - April 15, 2025 - Arineta, a leader in advancing cardiovascular imaging solutions, announces today its SpotLight™ cardiac CT scanner is now available at Boone Heart Institute in Greenwood Village, CO, supporting comprehensive, cardiac health in the greater Denver area. Advanced cardiovascular imaging with Arineta’s dedicated cardiac CT is a cornerstone of Boone’s Heart Disease and Stroke Prevention Program, promoting early detection to maintain and promote longevity.
In addition to providing care for the greater Denver community, the institute provides diagnostic and interventional cardiology care to retired professional athletes in the NFL and MLB as part of programs aimed at improving cardiovascular health of former athletes. These initiatives highlight the need for improved access to cardiac imaging and diagnostics, especially as adults considered to be in top physical condition like professional athletes are being diagnosed with heart disease, the deadliest disease in the country.
“We’ve seen patients from all walks of life come through our center including professional athletes, other physicians, international executives, and patients from around Denver. Our goal is to help each of them live to a healthy 100,” said Jeffrey L. Boone, MD, founder and medical director at Boone Heart Institute. “Arineta is a key addition to this initiative and we're proud to offer this new technology and elevate the standard of cardiac health in the Denver area.”
SpotLight is a single-beat, whole-heart scanner using deep-learning imaging reconstruction (DLIR) powered by artificial intelligence to enhance image clarity, delivering more precise and detailed cross-sectional images. Arineta’s cardiac CT scanner supports Boone’s integrated approach to healthcare, giving patients an all-encompassing view of their health and how the various systems in the body affect each other. The institute’s ongoing emphasis on preventative care seeks to identify conditions before they become a problem and intervene to limit the long-term impacts of a diagnosis, promoting whole-body health and longevity.
Arineta’s technology is currently being used in cardiology practices, imaging centers, and hospitals around the country, as well as in mobile scanning units bringing advanced cardiac CT directly to patients in underserved areas.
For more information, visit arineta.com.
About Arineta
Arineta, based in Israel, specializes in developing innovative cardiovascular imaging solutions. The company is committed to advancing cardiac CT as the front-line non-invasive method for diagnosing, planning therapy, and monitoring cardiovascular disease—the leading cause of death and healthcare costs worldwide. Arineta’s flagship product, the SpotLight™ Duo, based on the company’s proprietary Stereo CT technology, is the world’s first dedicated single-heartbeat, whole-heart cardiovascular and thoracic CT scanner. Building on its history of medical imaging innovation that began in Israel in the 1970s, Arineta’s team includes the inventors of multi-slice spiral CT technology, still the cornerstone of CT imaging, and several other key technologies.